Home/Pipeline/Spatial DNA Methylation (ATAC-TAPS+)

Spatial DNA Methylation (ATAC-TAPS+)

Research Use - Epigenetic Compartment Mapping

Advanced DevelopmentEarly Access/Pilot

Key Facts

Indication
Research Use - Epigenetic Compartment Mapping
Phase
Advanced Development
Status
Early Access/Pilot
Company

About AtlasXomics

AtlasXomics is a spatial biology company focused on bridging epigenomics and pathology to transform biomedical discovery. The company's core technology, DBiT-seq, is a spatial barcoding platform that enables multi-modal mapping of the epigenome and transcriptome at cellular resolution. With validation from over 170 labs worldwide and publications in top-tier journals, AtlasXomics is positioned as a leader in the emerging spatial epigenomics field, offering both innovative assay kits and a code-free bioinformatics pipeline to democratize access to this complex data.

View full company profile